Cancer Genomic Medicine Patient organization complains of legislation to prevent disadvantages December 5th 18:32
`` Cancer genomic medicine '' that examines genes and prescribes drugs according to patients makes it possible for cancer patients etc. to know that there is a risk of disadvantage such as refusal to join insurance if the risk of becoming cancer is revealed The group held a meeting and appealed for the enactment of laws to protect patients.
The “National Cancer Patients Association” was held in Tokyo, where medical staff and patients participated.
“Cancer Genomic Medicine” can be used to prescribe drugs suitable for each patient by examining genes, and there is a possibility that treatment may be found for patients who can no longer expect the effects of standard treatment The medical system has been put in place.
On the other hand, it has been pointed out that there is a risk of discrimination and disadvantages, such as knowing the risk of cancer from testing, and at the assembly, Associate Professor Yokono of Waseda University, who specializes in medical laws, actually After introducing the case where membership was refused, he pointed out that “a framework should be put in place so that anxiety and concerns remain”.
At the meeting, there were opinions from specialist doctors and patient groups asking for early enactment of laws to prevent disadvantages along with the promotion of cancer genomic medicine.
“I want you to promote cancer genomic medicine, but the efforts to prevent the disadvantages that should be promoted as two wheels are behind schedule compared to overseas. I want you to get it. "